ÂÜÀòÂÒÂ×

Olga Rutman is an experienced biostatistician currently serving as Associate Director Biostatistics at Mesoblast Limited since April 2019. Prior to this role, Olga worked at Roche from July 1992, holding various titles including Project Lead Statistician for Late Stage Oncology, where responsibilities included overseeing biostatistical activities for Tecentriq® in hematologic malignancies, and leading statistical efforts on early development oncology projects such as CD40 and GC33. Additional roles at Roche involved significant contributions to late-stage inflammation studies with Palovarotene and pivotal studies for Xeloda® and Kytril®. Olga also served as Director Biostatistics at Symphogen from August 2018 to December 2019.